Incyte
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.About INCY
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.
INCY Key Statistics
Stock Snapshot
With a market cap of 19.12B, Incyte(INCY) trades at $96.43. The stock has a price-to-earnings ratio of 14.99.
On 2026-04-11, Incyte(INCY) stock moved within a range of $95.45 to $97.53. With shares now at $96.43, the stock is trading +1.0% above its intraday low and -1.1% below the session's peak.
Trading volume for Incyte(INCY) stock has reached 1.15M, versus its average volume of 1.33M.
Over the past 52 weeks, Incyte(INCY) stock has traded between a high of $112.29 and a low of $55.11.
Over the past 52 weeks, Incyte(INCY) stock has traded between a high of $112.29 and a low of $55.11.
INCY News
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Incyte Corporation (Symbol: INCY) has taken over the #4...
RBC Capital analyst Brian Abrahams raised the firm’s price target on Incyte (INCY) to $95 from $92 and keeps a Sector Perform rating on the shares as part of th...
Incyte (INCY) is back in focus after releasing 54 week Phase 3 data for its JAK1 inhibitor povorcitinib in moderate to severe hidradenitis suppurativa, alongsid...
Analyst ratings
52%
of 29 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.